D-Index & Metrics Best Publications

Ola Myklebost

University of Bergen
Norway

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Genetics D-index 67 Citations 17,028 196 World Ranking 1757 National Ranking 6

Overview

What is he best known for?

The fields of study Ola Myklebost is best known for:

Gene
Cancer
Chromosome

Ola Myklebost combines Gene and Phenotype in his research. He undertakes multidisciplinary investigations into Genetics and Molecular biology in his work. Ola Myklebost applies his multidisciplinary studies on Molecular biology and Genetics in his research. Ola Myklebost undertakes multidisciplinary studies into Chromosome and Gene duplication in his work. He integrates Gene duplication with Chromosome in his study. In his work, Ola Myklebost performs multidisciplinary research in Karyotype and Trisomy. Trisomy and Aneuploidy are two areas of study in which Ola Myklebost engages in interdisciplinary research. Ola Myklebost integrates many fields, such as Aneuploidy and Karyotype, in his works. With his scientific publications, his incorporates both Comparative genomic hybridization and Cytogenetics.

His most cited work include:

Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes (176 citations)
Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization (109 citations)

What are the main themes of his work throughout his whole career to date

Gene connects with themes related to Somatic evolution in cancer in his study. Ola Myklebost incorporates Genetics and Cell biology in his studies. As part of his studies on Cell biology, Ola Myklebost frequently links adjacent subjects like Signal transduction. He conducts interdisciplinary study in the fields of Signal transduction and Downregulation and upregulation through his research. Ola Myklebost performs multidisciplinary study on Downregulation and upregulation and Apoptosis in his works. By researching both Apoptosis and Cell cycle checkpoint, he produces research that crosses academic boundaries. In his research, Ola Myklebost undertakes multidisciplinary study on Cancer research and Tumor suppressor gene. He merges Molecular biology with Complementary DNA in his research. Ola Myklebost performs multidisciplinary study on Complementary DNA and Molecular biology in his works.

Ola Myklebost most often published in these fields:

Gene (100.00%)
Genetics (92.31%)
Cancer research (53.85%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

Leming Shi;Laura H. Reid;Wendell D. Jones;Richard Shippy.
Nature Biotechnology (2006)

2353 Citations

Pan-cancer analysis of whole genomes

Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
(2020)

1275 Citations

Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.

J. Herz;U. Hamann;S. Rogne;Ola Myklebost.
The EMBO Journal (1988)

1158 Citations

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.

Christian Tovar;James Rosinski;Zoran Filipovic;Brian Higgins.
Proceedings of the National Academy of Sciences of the United States of America (2006)

759 Citations

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

Sam Behjati;Sam Behjati;Patrick S Tarpey;Nadège Presneau;Susanne Scheipl;Susanne Scheipl.
Nature Genetics (2013)

635 Citations

Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

Jose M. C. Tubio;Yilong Li;Young Seok Ju;Inigo Martincorena.
Science (2014)

363 Citations

Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

Emilie P. Buddingh;Marieke L. Kuijjer;Ronald A J Duim;Horst Bürger.
Clinical Cancer Research (2011)

349 Citations

Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs

Heidi M. Namløs;Leonardo A. Meza-Zepeda;Leonardo A. Meza-Zepeda;Tale Barøy;Ingrid H G Østensen.
PLOS ONE (2012)

295 Citations

Structure of the Supernumerary Ring and Giant Rod Chromosomes in Adipose Tissue Tumors

Florence Pedeutour;Anne Forus;Jean Michel Coindre;Jeanne Marie Berner.
Genes, Chromosomes and Cancer (1999)

281 Citations

Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.

Vivi Ann Flørenes;Steinar Aamdal;Ola Myklebost;Gunhild M. Maelandsmo.
Cancer Research (1992)

266 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Ola Myklebost